Eurofins Biopharma Product Testing India Private Limited - Company Profile

It is a travel and hospitality foreign private limited company based in Bangalore, Karnataka, India, established in 2021.

2021 Bangalore, Karnataka, India Active

Last Updated: December 27, 2025

Access Report

About Eurofins Biopharma Product Testing India Private Limited

Eurofins Biopharma Product Testing India Private Limited, a active foreign private limited company, was established on 29 July 2021 in Bangalore, Karnataka, India. Engaging in consumer professional services within the professional, scientific and technical sector, it holds CIN: U74999KA2021FTC150115. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.18 Cr.

Employing 41 professional, Its leadership includes Haladasappa Krishnappa (Additional Director), Pankaj Jaiminy (Additional Director). Past directors included Pradeep Narayan Phalke, Rajiv Malik, Ravikrishna Chebolu. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 21-22, Phase Ii, Peenya Industrial Area,, Bangalore, Karnataka, 560058.

Company Details

CIN/LLPIN
U74999KA2021FTC150115
Registration Number
150115
Incorporation Date
29 July 2021
Authorized Capital
₹2.50 Cr
Paid-Up Capital
₹2.18 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.50 Cr as on 27-12-2025
Paid Up Capital ₹ 2.18 Cr as on 27-12-2025
Company Age 4 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 75.43% (FY 2024)
Profit Growth **** 95.56% (FY 2024)
Ebitda **** 261.87% (FY 2024)
Net Worth 93.49% (FY 2024)
Total Assets **** 119.28% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Eurofins Biopharma Product Testing India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Eurofins Biopharma Product Testing India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Haladasappa Krishnappa	Additional Director	18 Jul 2025	Current
Pankaj Jaiminy	Additional Director	10 Sep 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	19 Apr 2024	Past
Pramod Abcsdd	Director	31 Dec 2024	Past
Pramod Abcsdd	Additional Director	-	Past
Pramod Abcsdd	Director	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eurofins Biopharma Product Testing India.

Eurofins Biopharma Product Testing India Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 75.43% increase. The company also saw a substantial improvement in profitability, with a 95.56% increase in profit. The company's net worth Soared by an impressive increase of 93.49%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

75.43%

*******

Revenue from Operations

*******

74.64%

*******

Total Assets

*******

119.28%

*******

Profit or Loss

*******

95.56%

*******

Net Worth

*******

93.49%

*******

EBITDA

*******

261.87%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eurofins Biopharma Product Testing India?

In 2023, Eurofins Biopharma Product Testing India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eurofins Biopharma Product Testing India?

Eurofins Biopharma Product Testing India has a workforce of 41 employees as of Nov 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Eurofins Biopharma Product Testing India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Biopharma Product Testing India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eurofins Biopharma Product Testing India

Recent Activity within the Organization

Annual General Meeting

Progress on Eurofins Biopharma Product Testing India Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
29 Sep 2025
Director Appointment

Progress on Pankaj Jaiminy was appointed as a Additional Director was appointed as a Additional Director on 10 Sep 2025 & has been associated with this company since 5 months 20 days . was documented.
10 Sep 2025
Director Appointment

Progress on Haladasappa Krishnappa was appointed as a Additional Director was appointed as a Additional Director on 18 Jul 2025 & has been associated with this company since 7 months 13 days . was documented.
18 Jul 2025
Balance Sheet

Eurofins Biopharma Product Testing India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
31 Mar 2025
Company Incorporation

Progress on Eurofins Biopharma Product Testing India Private Limited was registered on 29 Jul 2021 with Roc Bangalore & aged 4 years 7 months as per MCA records. was documented.
29 Jul 2021

Explore recent activity and updates - View Recent Activity